Table 1 Patient characteristics
| Â | Total | Retinal detachment | Non-retinal detachment | One injection subgroup | Retreatment subgroup |
|---|---|---|---|---|---|
Eye | 160 | 35 | 125 | 43 | 82 |
GA (weeks) | 30.0 ± 2.0 | 30.7 ± 2.0 | 29.8 ± 2.0 | 30.6 ± 2.3 | 29.53 ± 2.09 |
BW (g) | 1340 ± 334 | 1376 ± 374 | 1330 ± 323 | 1457 ± 418 | 1289 ± 296 |
PMA (weeks) | 36.6 ± 2.0 | 38.3 ± 2.0 | 36.2 ± 1.8 | 36.6 ± 2.1 | 36.09 ± 1.78 |
Gender (male/female) | 56/27 | 18/9 | 50/21 | 20/8 | 36/15 |
neutrophil count (*109/L) | 2.50 ± 1.53 | 1.95 ± 1.08 | 2.66 ± 1.60 | 2.77 ± 1.56 | 2.56 ± 1.63 |
lymphocyte count (*109/L) | 4.85 ± 1.50 | 4.91 ± 1.39 | 4.84 ± 1.53 | 4.59 ± 1.52 | 4.94 ± 1.53 |
NLR | median 0.47 (QAR 0.31–0.69) | 0.37 (0.19,0.60) | 0.49 (0.33,0.75) | 0.51 (0.36,0.80) | 0.480 (0.272,0.698) |